Clinical Trials and Pulmonary Fibrosis | American Lung Association

This website uses cookies. By continuing you are agreeing to our privacy policy.

Clinical Trials and Pulmonary Fibrosis

You may be a candidate for a clinical trial of a new pulmonary fibrosis (PF) treatment. Clinical trials are performed in order to test if experimental treatments are safe and effective for the treatment of a disease. Every drug that is approved today was once tested in a clinical trial.

Several research studies are being conducted about pulmonary fibrosis. Participating in a clinical trial may give you access to new treatment options and also help future PF patients. Some of the existing PF clinical trials are looking at drugs that can slow or block fibrosis, stem cell therapy and PF genes.

Talk to your doctor to find out if a clinical trial is right for you and visit our clinical trial section to learn more.


    Reviewed and approved by the American Lung Association Scientific and Medical Editorial Review Panel. Last reviewed February 5, 2018.

    Page Last Updated: March 13, 2018

    Sign up for updates

    Stay up to date on the latest news and information on the fight against pulmonary fibrosis.

    Red button with telephone
    Ask An Expert

    Questions about your lung health? Need help finding healthcare? Call 1-800-LUNGUSA.

    Get help
    Red button of two hand prints
    We need your generous support

    Make a difference by delivering research, education and advocacy to those impacted by lung disease.

    Button of turquoise LUNG FORCE swirl
    What is LUNG FORCE?

    LUNG FORCE unites women and their loved ones across the country to stand together in the fight against lung cancer.

    Get involved
    Join the fight for healthy lungs and healthy air.
    Donate Now.